| 1 | [SID87235992] | Chemical Probe | | | Summary of probe development efforts to identify inhibitors of Wee1 degradation [AID1807, Type: summary] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Chemical Probe | | BioAssay | Summary of probe development efforts to identify inhibitors of Wee1 degradation | | AID | 1807 | | BioAssay type | summary | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 2 | [SID87235992] | Chemical Probe | | | Summary of probe development efforts to identify inhibitors of Wee1 degradation [AID1807, Type: summary] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Chemical Probe | | BioAssay | Summary of probe development efforts to identify inhibitors of Wee1 degradation | | AID | 1807 | | BioAssay type | summary | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 3 | [SID87235992] | Chemical Probe | | | Summary of probe development efforts to identify inhibitors of Wee1 degradation [AID1807, Type: summary] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Chemical Probe | | BioAssay | Summary of probe development efforts to identify inhibitors of Wee1 degradation | | AID | 1807 | | BioAssay type | summary | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 4 | [SID99495575] | Active | AC50 | 1.79 | Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_Dose_CherryPick_Activity [AID652241, Type: confirmatory] | Vif [Human immunodeficiency virus 1] [gi:9629361] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | AC50 | 1.79 [uM] | | BioAssay | Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652241 | | BioAssay type | confirmatory | | Target | Vif [Human immunodeficiency virus 1] [gi:9629361] | | PubMed | | | Data Table |  |
|
| 5 | [SID99495575] | Active | Potency | 2.2387 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 6 | [SID99495575] | Active | Potency | 2.2387 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 7 | [SID99495575] | Active | IC50 | 2.971 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | IC50 | 2.971 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 8 | [SID99495575] | Active | IC50 | 2.971 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | IC50 | 2.971 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 9 | [SID99495575] | Active | IC50 | 2.971 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | IC50 | 2.971 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 10 | [SID87235992] | Active | EC50 | 6.188 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_1, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Active | | EC50 | 6.188 [uM] | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 11 | [SID87235992] | Active | EC50 | 6.188 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_1, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Active | | EC50 | 6.188 [uM] | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 12 | [SID87235992] | Active | EC50 | 6.188 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_1, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Active | | EC50 | 6.188 [uM] | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 13 | [SID99495575] | Active | IC50 | 8.229 | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID624395, Type: confirmatory] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | IC50 | 8.229 [uM] | | BioAssay | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 624395 | | BioAssay type | confirmatory | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 14 | [SID99495575] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 15 | [SID87235992] | Active | | | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Active | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 16 | [SID87235992] | Active | | | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Active | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 17 | [SID87235992] | Active | | | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Active | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 18 | [SID99495575] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] | | PubMed | | | Data Table |  |
|
| 19 | [SID99495575] | Active | | | Luminescence-based cell-based primary high throughput confirmation assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652260, Type: screening] | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput confirmation assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652260 | | BioAssay type | screening | | Target | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] | | PubMed | | | Data Table |  |
|
| 20 | [SID99495575] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 21 | [SID99495575] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 22 | [SID99495575] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 23 | [SID99495575] | Active | | | Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity [AID602346, Type: screening] | Vif [Human immunodeficiency virus 1] [gi:9629361] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602346 | | BioAssay type | screening | | Target | Vif [Human immunodeficiency virus 1] [gi:9629361] | | PubMed | | | Data Table |  |
|
| 24 | [SID99495575] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651611, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651611 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID99495575] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 26 | [SID99495575] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 27 | [SID99495575] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 28 | [SID99495575] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 29 | [SID99495575] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 30 | [SID99495575] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 31 | [SID99495575] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 32 | [SID99495575] | Active | | | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter [AID588350, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter | | AID | 588350 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID99495575] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter [AID588351, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter | | AID | 588351 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID99495575] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID99495575] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 36 | [SID99495575] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 37 | [SID87235992] | Unspecified | | | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_3, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Unspecified | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 38 | [SID87235992] | Unspecified | | | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_3, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Unspecified | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 39 | [SID87235992] | Unspecified | | | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_3, Type: screening] | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Unspecified | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | WEE1 homolog (S. pombe) [Homo sapiens] [gi:47123300] | | PubMed | | | Data Table |  |
|
| 40 | [SID99495575] | Inactive | Potency | 1.4125 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | Potency | 1.4125 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID99495575] | Inactive | AC50 | 52 | Identification of VIF Inhibitors- ruling Out Cytotoxic Compounds Measured in Cell-Based System Using Imaging - 2108-02_Inhibitor_Dose_CherryPick_Activity [AID652208, Type: confirmatory] | Vif [Human immunodeficiency virus 1] [gi:9629361] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | AC50 | 52 [uM] | | BioAssay | Identification of VIF Inhibitors- ruling Out Cytotoxic Compounds Measured in Cell-Based System Using Imaging - 2108-02_Inhibitor_Dose_CherryPick_Activity | | AID | 652208 | | BioAssay type | confirmatory | | Target | Vif [Human immunodeficiency virus 1] [gi:9629361] | | PubMed | | | Data Table |  |
|
| 42 | [SID87235992] | Inactive | EC50 | 55.69 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_2, Type: screening] | cyclin B1 [Homo sapiens] [gi:119571691] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Inactive | | EC50 | 55.69 [uM] | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | cyclin B1 [Homo sapiens] [gi:119571691] | | PubMed | | | Data Table |  |
|
| 43 | [SID87235992] | Inactive | EC50 | 55.69 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_2, Type: screening] | cyclin B1 [Homo sapiens] [gi:119571691] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Inactive | | EC50 | 55.69 [uM] | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | cyclin B1 [Homo sapiens] [gi:119571691] | | PubMed | | | Data Table |  |
|
| 44 | [SID87235992] | Inactive | EC50 | 55.69 | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. [AID2088_2, Type: screening] | cyclin B1 [Homo sapiens] [gi:119571691] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 87235992 | | CID | 44552613 | | Outcome | Inactive | | EC50 | 55.69 [uM] | | BioAssay | Late stage results from the probe development effort to identify inhibitors of Wee1 degradation. | | AID | 2088 | | BioAssay type | screening | | Target | cyclin B1 [Homo sapiens] [gi:119571691] | | PubMed | | | Data Table |  |
|
| 45 | [SID99495575] | Inactive | Potency | | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 46 | [SID99495575] | Inactive | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 47 | [SID99495575] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 48 | [SID99495575] | Inactive | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588792, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588792 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 49 | [SID99495575] | Inactive | | | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity [AID602329, Type: screening] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | BioAssay | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602329 | | BioAssay type | screening | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 50 | [SID99495575] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99495575 | | CID | 44552613 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|